USC Norris Comprehensive Cancer Center

Mesothelioma Care at USC Norris Comprehensive Cancer Center

A National Cancer Institute-designated Comprehensive Cancer facility, the Norris Comprehensive Cancer Center at the University of Southern California(USC) is a leader in both patient care and cancer research, offering the expertise of the scientists and physicians at USC’s Keck School of Medicine combined with the latest cutting-edge technology available to aid in the diagnosis, treatment and prevention of all types of cancer, like mesothelioma.

If qualified, cancer patients at Norris are offered participation in any number of clinical trials that are being conducted at the facility at any given time. The hospital’s teams of experts can determine whether or not their patients are eligible for consideration for these studies, which test new drugs (like Carboplatin, Gemcitabine and Alimta®) and treatments for cancer. Clinical trials offered at USC Norris Comprehensive Cancer Center are due to being awarded numerous grants, totaling more than $85 million.

Additionally, the researchers at Norris are divided into five thematic programs, which allow them to quickly bring their findings to the patients at the facility. These programs include molecular genetics, epigenetics and regulation, tumor microenvironment, cancer epidemiology and cancer control research.

USC Norris Comprehensive Cancer Center Specializations

• Cancer epidemiology
• Clinical trials
• Clinical oncology
• Tumor microenvironment

USC Norris Comprehensive Cancer Center Accreditations

• National Cancer Institute Designated Comprehensive Cancer Center

Mesothelioma Clinical Trials at USC Norris Comprehensive Cancer Center

Clinical trials can provide eligible mesothelioma patients with additional choices for their treatment. Information about whether trials may be available at USC Norris Comprehensive Cancer Center can be found below: